Blu Pharmaceuticals Inc

FDA Regulatory Profile

Blu Pharmaceuticals Inc appears in FDA public data with 2 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1301-2014, Class II) was initiated on March 13, 2014.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1301-2014Class IIMetformin Hydrochloride Tablets USP 500 mg, 500 tablets Rx Only, Manufactured by Blu Caribe Dorado PMarch 13, 2014
D-1302-2014Class IIMetformin Hydrochloride Tablets USP 1000 mg, 500 tablets Rx Only, Manufactured by Blu Caribe Dorado March 13, 2014